Denver Regenerative Medicine - What is regenerative medicine?
Dr. Joel Cherdack of Denver Regenerative Medicine explains what regenerative medicine is. He and the hosts discuss the benefits of both PRP (platelet rich plasma) and Stem Cell Therapy.
By: Denver Regenerative Medicine
See the original post:
Denver Regenerative Medicine - What is regenerative medicine? - Video
Stem Cell Therapy + PRP Helps Shoulder Injury and Whiplash Patient - Denise Lawson
Denise Lawson experienced two motor vehicle accidents in 2001 that left her with neck pain, headaches, and sporadic episodes of weakness on the left side of her body. Over time, Denise developed...
By: StemCell ARTS
Go here to read the rest:
Stem Cell Therapy + PRP Helps Shoulder Injury and Whiplash Patient - Denise Lawson - Video
By Sheryl Ubelacker, The Canadian Press
TORONTO - Gordie Howe's son says the hockey legend's stroke symptoms have improved since his treatment with stem cells at a Mexican clinic in early December and he wants him to repeat the procedure.
But regenerative medicine experts say there's no scientific evidence such therapies work, and in some cases they can be seriously harmful or even deadly.
The 86-year-old Howe suffered two disabling strokes late last year. In December, the family took him to a Tijuana clinic where he received stem cell injections as part of a clinical trial being run under a licensing agreement with Stemedica Cell Technologies of San Diego, Calif.
The experimental treatment involved injecting neural stem cells into Howe's spinal canal, along with intravenous infusions of mesenchymal stem cells, which are found in bone marrow, fat and umbilical cord blood.
Marty Howe said his father can walk again, his speech is improving and he is regaining some of the weight he lost following the strokes.
"After his stem cell treatment, the doctor told us it was kind of an awakening of the body, and it was all that," he told The Canadian Press while in Calgary for a hockey promotion event Tuesday. "They call it the miracle of stem cells and it was nothing less than a miracle."
However, experts in the field question whether stem cells are responsible for Howe's improvement and caution that most so-called stem cell therapies have not gone through rigorous scientific trials, nor have they been approved as treatments by Health Canada or the U.S. Food and Drug Administration.
Mick Bhatia, director of McMaster University's Stem Cell and Cancer Research Institute, said there are many unknowns in Howe's case, such as how many stem cells were administered, were tests done to see whether they migrated to the targeted area of the body, and did they take up residence where they might have some effect or simply disappear?
"Is this a transient effect, or is it really a perceived or somewhat of a placebo effect and is there something really happening? Scientifically and biologically that is important," Bhatia said Wednesday from Hamilton.
See original here:
Howe's stem cell treatment raises concerns
TORONTO - Gordie Howe's son says the hockey legend's stroke symptoms have improved since his treatment with stem cells at a Mexican clinic in early December and he wants him to repeat the procedure.
But regenerative medicine experts say there's no scientific evidence such therapies work, and in some cases they can be seriously harmful or even deadly.
The 86-year-old Howe suffered two disabling strokes late last year. In December, the family took him to a Tijuana clinic where he received stem cell injections as part of a clinical trial being run under a licensing agreement with Stemedica Cell Technologies of San Diego, Calif.
The experimental treatment involved injecting neural stem cells into Howe's spinal canal, along with intravenous infusions of mesenchymal stem cells, which are found in bone marrow, fat and umbilical cord blood.
Marty Howe said his father can walk again, his speech is improving and he is regaining some of the weight he lost following the strokes.
"After his stem cell treatment, the doctor told us it was kind of an awakening of the body, and it was all that," he told The Canadian Press while in Calgary for a hockey promotion event Tuesday. "They call it the miracle of stem cells and it was nothing less than a miracle."
However, experts in the field question whether stem cells are responsible for Howe's improvement and caution that most so-called stem cell therapies have not gone through rigorous scientific trials, nor have they been approved as treatments by Health Canada or the U.S. Food and Drug Administration.
Mick Bhatia, director of McMaster University's Stem Cell and Cancer Research Institute, said there are many unknowns in Howe's case, such as how many stem cells were administered, were tests done to see whether they migrated to the targeted area of the body, and did they take up residence where they might have some effect or simply disappear?
"Is this a transient effect, or is it really a perceived or somewhat of a placebo effect and is there something really happening? Scientifically and biologically that is important," Bhatia said Wednesday from Hamilton.
And because Howe received adult stem cells produced from donor cells, he may have needed to take drugs to prevent an immune reaction as well as anti-inflammatory medications, he said.
More here:
Gordie Howe's stem cell therapy raises concerns among experts
Sheryl Ubelacker, The Canadian Press Published Thursday, January 29, 2015 6:49AM EST
TORONTO -- Gordie Howe's son says the hockey legend's stroke symptoms have improved since his treatment with stem cells at a Mexican clinic in early December and he wants him to repeat the procedure.
But regenerative medicine experts say there's no scientific evidence such therapies work, and in some cases they can be seriously harmful or even deadly.
The 86-year-old Howe suffered two disabling strokes late last year. In December, the family took him to a Tijuana clinic where he received stem cell injections as part of a clinical trial being run under a licensing agreement with Stemedica Cell Technologies of San Diego, Calif.
The experimental treatment involved injecting neural stem cells into Howe's spinal canal, along with intravenous infusions of mesenchymal stem cells, which are found in bone marrow, fat and umbilical cord blood.
Marty Howe said his father can walk again, his speech is improving and he is regaining some of the weight he lost following the strokes.
"After his stem cell treatment, the doctor told us it was kind of an awakening of the body, and it was all that," he told The Canadian Press while in Calgary for a hockey promotion event Tuesday. "They call it the miracle of stem cells and it was nothing less than a miracle."
However, experts in the field question whether stem cells are responsible for Howe's improvement and caution that most so-called stem cell therapies have not gone through rigorous scientific trials, nor have they been approved as treatments by Health Canada or the U.S. Food and Drug Administration.
Mick Bhatia, director of McMaster University's Stem Cell and Cancer Research Institute, said there are many unknowns in Howe's case, such as how many stem cells were administered, were tests done to see whether they migrated to the targeted area of the body, and did they take up residence where they might have some effect or simply disappear?
"Is this a transient effect, or is it really a perceived or somewhat of a placebo effect and is there something really happening? Scientifically and biologically that is important," Bhatia said Wednesday from Hamilton.
Link:
Gordie Howe's stem cell therapy raises concerns among medical experts
MIAMI (PRWEB) January 29, 2015
Regenestem Network, the worlds largest membership network of regenerative medicine practitioners, has announced the launch of a new stem cell clinic in Oaxaca, Mexico. The new facility, offering the most advanced cellular medicine protocols and techniques available is in partnership with Ulises Cervera, M.D. a neurologist coming from the Children's Hospital of Morelia, Mexico.
The new Oaxaca facility will offer the most advanced protocols and techniques available in stem cell medicine to patients from across Mexico and around the world.
Global Stem Cells Group and Regenestem Network are expanding the companys clinical presence worldwide by partnering with experienced and qualified regenerative medicine physicians to open new clinics licensed and developed under the Regenestem banner.
In 2014, Global Stem Cells Group expanded the Regenestem Networks global presence to 20 countries.
Regenestem offers stem cell treatments to help treat a variety of diseases and conditions including arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes, and pain due to injuries at various facilities worldwide. Regenestem Oaxaca will have an international staff experienced in administering the latest in cellular therapies.
Regenestem is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. Regenestem clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.
The Global Stem Cells Group and Regenestem are committed to the highest of standards in service and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.
For more information, visit the Regenestem Network website, email info(at)regenstem(dot)com, or call 305-224-1858.
About Regenestem: Regenestem Network, a division of the Global Stem Cells Group, Inc., is an international medical practice association committed to researching and producing comprehensive stem cell treatments for patients worldwide. Having assembled a highly qualified staff of medical specialistsprofessionals trained in the latest cutting-edge techniques in cellular medicineRegenestem continues to be a leader in delivering the latest protocols in the adult stem cell arena.
IMAGE:This is Carla Kim, PhD, of the Boston Children's Hospital Stem Cell Research Program. view more
Credit: Boston Children's Hospital
BOSTON (January 28, 2015) -- An existing drug may help some patients with non-small-cell lung cancer (NSCLC) whose tumors have become resistant to chemotherapy, finds a study from Boston Children's Hospital and the Dana-Farber Cancer Institute (DFCI). The findings, in human cancer cells and in mice, suggest a window of vulnerability in NSCLC, the leading cause of cancer-related deaths worldwide.1 The work was published online today by the journal Nature.
NSCLC is a highly genetically complex cancer with many different subtypes, each bearing different mutations. In two common subtypes that do not respond to standard chemotherapy--tumors with BRG1 or EGFR mutations--the researchers increased the effectiveness of etoposide, a common chemotherapy agent, by adding an epigenetic therapy already in clinical testing.
Conversely, when the same epigenetic therapy (inhibition of an enzyme known as EZH2) was added to certain tumors without BRG1 and EGFR mutations, the tumors become more resistant to chemotherapy. Together, the findings advance the idea of individualized, "precision medicine" in cancer, incorporating epigenetic therapy guided by tumor genetic testing.
The study also suggests that genetic tumor testing should screen for mutations in BRG1, a natural tumor suppressor. This test is not done widely now, although testing does look for EGFR mutations and other known cancer "driver" mutations. An estimated 10 percent of patients with NSCLC have BRG1 mutations, and this genetic subtype currently lacks a targeted therapy.
"Etoposide plus an EZH2 inhibitor could be a first-line therapy for BRG1-mutant tumors, and a treatment option for EGFR-mutant tumors that are resistant to tyrosine kinase inhibitors," says Christine Fillmore, PhD, of Boston Children's Hospital's Stem Cell Research Program, the study's first author.
EZH2 has been strongly linked with cancer progression and is part of a complex of molecules that determine which genes in a cell are turned "on" or "off"--part of the cell's so-called epigenome. Epigenetic therapy has become a hot area in cancer research, and EZH2 inhibitors are in phase I/II trials for other cancers, including B cell lymphomas and malignant rhabdoid tumors.
However, the use of EZH2 inhibitors in lung cancer has needed more rationale in preclinical studies, says oncologist Kwok-Kin Wong, MD, PhD, professor of medicine at DFCI and Harvard Medical School and a collaborator on the study. The researchers hope their findings will inspire the pharmaceutical industry to test EZH2 inhibitors together with chemotherapy in patients whose tumors have BRG1 or EGFR mutations.
"This study provides better predictive information as to which cancer patients will respond to EZH2 inhibitors, and shows that even epigenetic therapy needs to be specified to a genotype," says senior author Carla Kim, PhD, an associate professor at Boston Children's Stem Cell Program and the Department of Genetics at Harvard Medical School.
Read the rest here:
Epigenetic drug boosts chemotherapy's efficacy in some lung cancers
Arthritic knees three months after bone marrow stem cell therapy by Harry Adelson, N.D.
Holly, three-time World Cup Downhill Gold Medalist and Olympian, discusses her outcome from bone marrow stem cells for her arthritic knees performed at Docere Clinics http://www.docereclinics.com.
By: Harry Adelson, N.D.
See more here:
Arthritic knees three months after bone marrow stem cell therapy by Harry Adelson, N.D. - Video
Gordie Howe has responded so well to stem cell treatment that his son Marty wants the Hockey Hall of Famer to undergo the procedure again.
Gordie suffered two strokes late last year and had maybe a month to live, Marty said, when his family took the 86-year-old to Mexico in December for the treatment.
Gordie Howe can walk again, his speech is improving and hes gained weight that he lost, according to his son.
He is doing so much better, Marty said Tuesday in Calgary. Its a joy to have him with us still.
Hopefully, in my mind, were going to have another treatment of this probably within two months.
Im actually hoping if he keeps doing what hes doing hell be able to travel again and maybe get to five or six events a year so people can see him another time.
Gordie Howe, known as Mr. Hockey, holds NHL records for most games played (1,767) and seasons played (26). He won the Stanley Cup four times as a Detroit Red Wing and also played for the Hartford Whalers.
His 801 career goals rank second only to Wayne Gretzkys 894.
Gordie Howe and Gretzky are scheduled to appear Feb. 6 in Saskatoon at a dinner, which Marty said will be a trial run on how his father responds to travel.
Marty Howe was in Calgary alongside NHL alumni Darryl Sittler, Marty McSorley and Lanny McDonald to promote a pro-am hockey tournament in Gordies name that raises money for Alzheimers and dementia research.
Read more here:
Experimental stem cell treatment key in Gordie Howes dramatic improvement
Got too much scalp? A new way to treat hair loss that doesnt involve solutions, creams or hocus-pocus could be on the way.
Scientists at the Sanford-Burnham Medical Research Institute have developed a stem cell method that initiates human hair growth.
Stem Cell Treatment Cures Blindness
Stem cells are the baseline, progenitor cells of all cells in our body. Using a genetic technique, Alexey Terskikh, an associate professor at the institute, and his colleagues coaxed stem cells to become dermal papilla cells.
These cells regulate the formation and growth cycle of hair follicles.
When transplanted into lab mice, the dermal papilla cells promoted the growth of hair.
Stem Cells Grow Beating Heart
Our next step is to transplant human dermal papilla cells derived from human pluripotent stem cells back into human subjects, said Terskikh. We are currently seeking partnerships to implement this final step.
Snake-oil salesmen need not apply.
via Sanford-Burnham Medical Research Institute
Read more here:
Stem Cells Could Treat Hair Loss